NEW YORK (GenomeWeb) – RayBiotech today announced a partnership with XCellCure to develop a cardiovascular disease diagnostic kit.

The firms will co-market and co-distribute the kits worldwide with a focus initially on the research market and the longer term goal of making the technology available to the clinical diagnostics and prognostics spaces.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.